Urgent.News

What's breaking now, across thousands of outlets.

AI

Commentary: Singapore’s next big technology bet cannot wait till we’ve figured out AI

AI is today’s imperative. Quantum may be tomorrow’s advantage. The country must invest in both, say SGTech’s Gavin Chua and Gunasekharan Chellappan.

Commentary: Singapore’s next big technology bet cannot wait till we’ve figured out AI

In Singapore, the adoption of AI is outpacing the readiness of many organizations, as employees independently experiment with the technology while companies struggle with implementation. The Economic Strategy Review (ESR) emphasizes that Singapore must invest in both AI and quantum computing, rather than choosing between the two.

Quantum computing may offer advantages in the future, but its widespread commercial use is yet to be achieved. Singapore's success in technology has always come from simultaneously adopting useful technologies and investing in those with long-term potential. Quantum computing, like AI, could complement existing technologies in various industries, such as cybersecurity, where quantum computers may eventually break current encryption standards.

To prepare for these advancements, Singapore should focus on developing interdisciplinary expertise and fostering an ecosystem that brings together industry, government, academia, and investors. This collaborative approach will ensure that businesses are prepared for emerging technologies without being overwhelmed by the need to implement them immediately.

Written by urgent.news from CNA - Singapore's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at channelnewsasia.com →

More in AI

Anthropic's Claude Joins 6 Drug Firms Hunting A Cure For Rare Muscle Disease

Anthropic is teaming up with six drug companies, including Bristol Myers Squibb, to use its Claude AI in the hunt for treatments for a rare muscle-wasting disease that strikes children.

  • Anthropic partners with six drug firms to use Claude AI for rare muscle disease treatment.
  • Anthropic's Claude integrated into drug discovery program, targeting multiple pipeline bottlenecks.

More from Tuesday 27 October →